Camrelizumab Combined With Chemotherapy Followed by Camrelizumab Plus Apatinib as First-Line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Camrelizumab Combined With Chemotherapy Followed by Camrelizumab Plus Apatinib as First-Line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clin. Cancer Res 2021 Mar 25;[EPub Ahead of Print], Z Peng, J Wei, F Wang, J Ying, Y Deng, K Gu, Y Cheng, X Yuan, J Xiao, Y Tai, L Wang, JJ Zou, Y Zhang, L ShenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.